Yang, Y, et al.
The transmissibility and control of pandemic influenza A (H1N1) virus. Science
2009; 326: 729–733.
Fenichel, EP, et al.
Adaptive human behavior in epidemiological models. Proceedings of the National Academy of Sciences USA
2011; 108: 6306–6311.
Ferguson, N. Capturing human behaviour. Nature
2007; 446: 733.
Epstein, JM, et al.
Coupled contagion dynamics of fear and disease: mathematical and computational explorations. PLoS ONE
2008; 3: e3955.
Funk, S, Salathé, M, Jansen, VA. Modelling the influence of human behaviour on the spread of infectious diseases: a review. Journal of the Royal Society Interface
2010; 7: 1247–1256.
Gross, T, D'Lima, CJ, Blasius, B. Epidemic dynamics on an adaptive network. Physical Review Letters
2006; 96: 208701.
Funk, S, et al.
The spread of awareness and its impact on epidemic outbreaks. Proceedings of the National Acad-emy of Sciences USA
2009; 106: 6872–6877.
Perisic, A, Bauch, CT. A simulation analysis to characterize the dynamics of vaccinating behaviour on contact networks. BMC Infectious Diseases
2009a; 9: 77.
Perisic, A, Bauch, CT. Social contact networks and disease eradicability under voluntary vaccination. PLoS Computational Biology
2009; 5: e1000280.
Wallinga, J, Teunis, P, Kretzschmar, M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. American Journal of Epidemiolgy
2006; 164: 936–944.
Chen, SC, et al.
Use of seasonal influenza virus titer and respiratory symptom score to estimate effective human contact rates. Journal of Epidemiology
2012; 22; 353–363.
Handel, A, Longini, IM Jr., Antia, R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Computational Biology
2007; 3: e240.
Cowling, BJ, et al.
Comparative epidemiology of pandemic and seasonal influenza A in households. New England Journal of Medicine
2010; 362: 2175–2184.
Nichol, KL, et al.
Modeling seasonal influenza outbreak in a closed college campus: Impact of pre-season vaccination, in-season vaccination and holidays/break. PLoS ONE
2010; 5: e9548.
Anderson, RM, May, RM. Infectious Diseases of Humans. Dynamics and Control. Oxford: Oxford University Press, 1992.
Longini, IM Jr., et al.
Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity. International Journal of Epidemiology
1984; 13: 496–501.
Hayden, FG, et al.
Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. Journal of the American Medical Association
1996; 275: 295–299.
Liao, CM, et al.
Understanding the influenza virus-specific epidemiological properties by analysis of experimental human infections. Epidemiology and Infection
2010; 138: 825–835.
Opatowski, L, et al.
Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 southern hemisphere countries. PLoS Pathogens
2011; 7: e1002225.
McCaw, JM, et al.
Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks. BMC Infectious Diseases
2010; 10: 166.
Mikolajczyk, RT, et al.
Social contacts of school children and the transmission of respiratory-spread pathogens. Epidemiology Infection
2008; 136: 813–822.
Hayden, FG, et al.
Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. Journal of Clinical Investigation
1998; 101: 643–649.
Fritz, RS, et al.
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. Journal of Infectious Diseases
1999; 180: 586–593.
Brauer, F. A simple model for behaviour change in epidemics. BMC Public Health
2011; 11: S3.
Jefferson, T, et al.
Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. British Medical Journal
2008; 336: 77–80
World Health Organization Writing Group, et al.
Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerging Infectious Diseases
2006; 12: 88–94.
Aledort, JE, et al.
Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health
2007; 7: 208.
Cauchemez, S, et al.
Closure of schools during an influenza pandemic. Lancet Infectious Diseases
2009; 9: 473–481.
Hsueh, PR, et al.
Pandemic (H1N1) 2009 vaccination and class suspensions after outbreaks, Taipei City, Taiwan. Emerging Infectious Diseases
2010; 16: 1309–1311.
Inglesby, TV, et al.
Disease mitigation measures in the control of pandemic influenza. Biosecurity and Bio-terrorism – Biodefense Strategy Practice and Science
2006; 4: 366–375.
Borse, RH, et al.
Closing schools in response to the 2009 pandemic influenza A H1N1 virus in New York City: economic impact on households. Clinical Infectious Diseases
2011; 52: S168–172.
House, T, et al.
Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proceedings of the Royal Society of London, Series B: Biological Sciences
2011; 278: 2753–2760.
Wu, JT, et al.
School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerging Infectious Diseases
2010; 16: 538–541.
Bhattarai, A, et al.
Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak – Pennsylvania, May–June 2009. Clinical In-fectious Diseases
2011; 52: S102–108.